The investigators found that poor tumor perfusion, as measured by multiparametric methods, correlated with high expression levels of vascular endothelial growth factor A (VEGFA) and immune checkpoints, cluster of differentiation 274 (CD274) and cytotoxic T-lymphocyte-associated-protein 4 (CTLA4) [12]. The gene discussed is CTLA4; the disease is neoplasm.